(19)
(11) EP 4 565 209 A1

(12)

(43) Date of publication:
11.06.2025 Bulletin 2025/24

(21) Application number: 23753882.2

(22) Date of filing: 04.08.2023
(51) International Patent Classification (IPC): 
A61K 9/127(2025.01)
C12Q 1/68(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/68; A61K 9/1271; A61K 9/5123
 
C-Sets:
C12Q 1/68, C12Q 2563/155, C12Q 2563/159, C12Q 2563/173;
(86) International application number:
PCT/EP2023/071712
(87) International publication number:
WO 2024/028492 (08.02.2024 Gazette 2024/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 04.08.2022 EP 22315177

(71) Applicant: Sanofi Pasteur Inc.
Swiftwater, PA 18370 (US)

(72) Inventors:
  • NOUGAREDE, Adrien
    75017 Paris (FR)
  • VALADON, Charlène
    75017 Paris (FR)

(74) Representative: Lavoix 
2, place d'Estienne d'Orves
75441 Paris Cedex 09
75441 Paris Cedex 09 (FR)

   


(54) QUANTITATIVE ASSESSMENT OF RNA ENCAPSULATION